AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Urocrid 0.4 Tablet MR

Prescription Icon
Prescription Required

Marketer

Biosortia Healthcare Pvt Ltd

Salt Composition

Tamsulosin (0.4mg)

Overview Urocrid 0.4 Tablet MR

Tamsulosin 0.4mg Modified-Release tablets are an alpha-blocker indicated for managing benign prostatic hyperplasia (BPH). This medication alleviates urinary symptoms such as hesitancy, but doesn't shrink the prostate gland. Always adhere to your physician's prescribed dosage and regimen. It can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Consult your doctor immediately if you experience any persistent or bothersome side effects, such as lightheadedness, back discomfort, chest pain, altered ejaculation, or retrograde ejaculation. Simple lifestyle adjustments can improve symptom control. Void your bladder promptly upon feeling the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeinated or alcoholic beverages. Disclose all current medications to your doctor before commencing treatment. Inform your ophthalmologist about Tamsulosin use prior to cataract or glaucoma surgery. Patients with hepatic impairment should exercise caution, requiring closer monitoring by their healthcare provider.

Uses of Urocrid 0.4 Tablet MR

Managing benign prostatic hyperplasia

Major Benefits of Urocrid 0.4 Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Urocrid 0.4mg Modified-Release tablet whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, though consistent timing is recommended.

Common Side effects of Urocrid 0.4 Tablet MR:

  • Chest pain
  • Inflammation of the nose
  • Dizziness
  • Ejaculation disorder
  • Headache
  • Abdominal pain
  • Back pain
  • Nausea
  • Infection

How to use Urocrid 0.4 Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Urocrid 0.4 mg Modified-Release tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.

How Urocrid 0.4 Tablet MR works:

Urocrid 0.4 MR tablets contain an alpha-blocking agent that eases urination. The medication achieves this by relaxing muscles in the prostate and bladder neck, thereby facilitating more complete bladder emptying and lessening urinary frequency and urgency associated with benign prostatic hyperplasia (BPH).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Urocrid 0.4 MR tablets with alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Urocrid 0.4 Tablet MR use in pregnancy is lacking. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Urocrid 0.4 Tablet MR while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.

DrivingDrivingSAFE

Driving ability is typically unaffected by Urocrid 0.4 MR tablets.

KidneyKidneySAFE IF PRESCRIBED

Urocrid 0.4 MR tablets are considered safe for individuals with kidney impairment, and no dosage modification is typically advised. Nevertheless, data regarding Urocrid 0.4 MR tablet use in patients experiencing end-stage renal disease remains scant. Physician consultation is recommended.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Urocrid 0.4 mg modified-release tablets. Dosage modification of Urocrid 0.4 mg modified-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Urocrid 0.4 Tablet MR :

Should you forget to take a Urocrid 0.4 MR tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Urocrid 0.4 Tablet MR

LabelValue
Type of Compound Sulfonylamide-based compound
Potential for Dependence None.
Type of Medication The study of the urinary tract and male reproductive system.

FAQs on Urocrid 0.4 Tablet MR

Consume the capsule either after breakfast or your first meal. Alternatively, some physicians recommend nighttime ingestion following dinner. Consistent daily timing is important; take it about 30 minutes after the chosen meal. Ingest the capsule whole with water. Avoid crushing, chewing, or opening the medication.
Urocrid 0.4 MR tablets do not elevate blood glucose. However, should you observe altered blood sugar readings during treatment, seek medical advice; this may indicate an unrelated health issue requiring management.
Urocrid 0.4 MR tablets typically do not lead to weight increase, even with prolonged administration. However, should you notice weight gain while using this medication, seek medical advice to determine the underlying reason.
Noticeable increases in urinary output may occur between four and eight hours following ingestion of a 0.4 mg modified-release Urocrid tablet. Complete therapeutic benefit, however, might require two to four weeks.
Concurrent use of Urocrid 0.4 MR tablets and vitamin D supplements is considered safe, with no known adverse reactions or interactions documented.
For individuals experiencing kidney stones, Urocrid 0.4 Tablet MR facilitates stone expulsion through urination. Its mechanism involves urinary tract muscle relaxation, easing stone passage. Urocrid 0.4 Tablet MR administration in kidney stone cases also reduces the requirement for analgesics.
Urocrid 0.4 MR tablets cause vasodilation, resulting in peripheral blood pooling. This reduced cerebral blood flow leads to postural hypotension, potentially manifesting as dizziness, lightheadedness, syncope, vertigo, or a spinning sensation.
Mydriasis insufficiency, a potential side effect of Urocrid 0.4 MR tablets, manifests as weakened iris muscles. This can lead to unintended pupil constriction during cataract surgery, hindering the surgeon's view and potentially compromising surgical results due to a restricted surgical field.
The sustained-release Urocrid 0.4mg tablet reduces tension in the blood vessel's smooth muscle; this vascular dilation may lead to nasal congestion.
Urocrid 0.4 MR tablets do not belong to the anticholinergic drug class. This medication works by easing prostate and bladder neck muscle tension, thereby enhancing urinary flow for individuals with benign prostatic hyperplasia. Concurrent use of anticholinergics with Urocrid 0.4 MR tablets may exacerbate symptoms and worsen the underlying condition.
Urocrid 0.4 MR tablets do not induce frequent urination. Instead, this medication enhances urine flow and reduces the urge to urinate often, a common symptom of benign prostatic hyperplasia. This condition also causes a weak urinary stream, preventing complete bladder emptying. Urocrid 0.4 MR tablets address these urinary symptoms associated with benign prostatic hyperplasia.
Patients with benign prostatic hyperplasia typically experience no adverse reactions from Urocrid 0.4 Tablet MR. Prolonged Urocrid 0.4 Tablet MR use, however, might elevate the risk of infections, nasal inflammation, pain, and throat inflammation. Extended treatment may additionally lead to ejaculatory dysfunction, syncope, lightheadedness, vertigo, and hypotension.
Modifying your daily habits can improve symptom control. Respond promptly to the urge to void your bladder. Nevertheless, avoid straining during urination. Restrict fluid intake, particularly alcohol and caffeinated beverages, in the hours preceding sleep or outings. Furthermore, avoid self-medicating; consult your physician before taking any additional medications, as some may exacerbate urinary frequency.
The extended-release Urocrid 0.4 mg tablet may be administered concurrently with ibuprofen or acetaminophen. Combined use has not revealed adverse reactions or drug interactions.
Urocrid 0.4 Tablet MR
81
MRP 99
18% off